Meeting
2023 ASCO Annual Meeting
Safety of checkpoint inhibitors in older patients with genitourinary cancers.
Authors
Brian Hemendra Ramnaraign
University of Florida/UF Health Cancer Center, Gainesville, FL
Brian Hemendra Ramnaraign , Neil Jigish Patel , Jonathan Alexander Chatzkel , Kathryn Hitchcock , Robert Zlotecki , Padraic O'Malley , Paul Crispen
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Symptoms and Survivorship
Track
Symptom Science and Palliative Care
Sub Track
Geriatric Models of Care
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 12059)
DOI
10.1200/JCO.2023.41.16_suppl.12059
Abstract #
12059
Poster Bd #
427
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Distribution of immune-related adverse events (irAEs) across genitourinary (GU) malignancies.
First Author: Nataliya Mar
Poster
2024 ASCO Annual Meeting
Early combination with mycophenolate mofetil for immune-related hepatitis in patients with solid tumors treated with immune checkpoint inhibitors.
First Author: Yukiko Shimoda Igawa
Poster
2021 Genitourinary Cancers Symposium
Safety and efficacy outcomes in immune checkpoint inhibitor (ICI)-treated metastatic urothelial carcinoma (mUC) patients (pts) requiring treatment interruption (TI) due to immune-related adverse events (irAEs).
First Author: Amanda Nizam
Poster
2019 ASCO Annual Meeting
Cardiovascular complications of immune checkpoint inhibitor therapy.
First Author: Samip R. Master